Clinical Trials
3 trialsNCT05013450 2025-12-17
Dupilumab_Metastatic NSCLC
Icahn School of Medicine at Mount Sinai
Phase 1/2 Active not recruiting
NCT06088771 2025-05-08
Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC
Icahn School of Medicine at Mount Sinai
Phase 1/2 Recruiting
NCT06743581 2024-12-20
Dupi-Cemi
Centre hospitalier de l'Université de Montréal (CHUM)
Phase NA Not yet recruiting